
BSJ-03-123 is a мощный, CDK6-селективный small-molecule degrader (PROTAC). Pharmacologic CDK6 degradation targets a селективный dependency of acute myeloid leukemia cells, and transcriptomics and phosphoproteomics profiling of acute degradation of CDK6 enabled dynamic mapping of its immediate role in coordinating signaling and transcription.
BSJ-03-123 is a potent, CDK6-selective small-molecule degrader (PROTAC). Pharmacologic CDK6 degradation targets a selective dependency of acute myeloid leukemia cells, and transcriptomics and phosphoproteomics profiling of acute degradation of CDK6 enabled dynamic mapping of its immediate role in coordinating signaling and transcription.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.